Brett Gm Hughes

9PUBLICATIONS
34CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Epidemiological modellingPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Jul 21, 2025
Response-Adapted Surgical and Radiotherapy De-Escalation in Resectable Cutaneous Squamous Cell Cancer Using Pembrolizumab: The De-Squamate Study.

Rahul Ladwa, Jenny H Lee, Margaret McGrath

|Jun 18, 2025
Neoadjuvant and Adjuvant Pembrolizumab in Locally Advanced Head and Neck Cancer.

Ravindra Uppaluri, Robert I Haddad, Yungan Tao

|Oct 11, 2022
Pembrolizumab With or Without Chemotherapy in Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma: Updated Results of the Phase III KEYNOTE-048 Study.

Kevin J Harrington, Barbara Burtness, Richard Greil

|Sep 12, 2022
Neoadjuvant Cemiplimab for Stage II to IV Cutaneous Squamous-Cell Carcinoma.

Neil D Gross, David M Miller, Nikhil I Khushalani

|Jun 10, 2022
Understanding the tumor microenvironment in head and neck squamous cell carcinoma.

Habib Sadeghi Rad, Yavar Shiravand, Payar Radfar

Pageof 2